Related Experiment Video

Updated: Apr 10, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.9K

[Current Treatment of Stable Angina]

Stefan Toggweiler1, Peiman Jamshidi, Florim Cuculi

  • 11 Herzzentrum, Abteilung Kardiologie, Luzerner Kantonsspital.

Praxis
|June 18, 2015
PubMed

Insights

Current stable angina therapy focuses on revascularization and lifestyle changes like smoking cessation and exercise. Medical management of risk factors remains crucial, though antianginal drugs are less emphasized due to improved revascularization accessibility.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Preventive Cardiology

Context:

  • Stable angina management has evolved with advances in revascularization techniques.
  • Lifestyle modifications, including smoking cessation and regular exercise, are critical for preventing cardiovascular events.
  • Medical therapy for cardiovascular risk factors and antithrombotic management presents ongoing challenges.

Purpose:

  • To provide a contemporary overview of stable angina management strategies.
  • To highlight the current therapeutic landscape for patients with stable angina in 2015.

Summary:

  • Current therapeutic options for stable angina encompass surgical and percutaneous revascularization, alongside lifestyle interventions.
  • The importance of antianginal therapy has diminished with increased accessibility to coronary revascularization procedures.
  • Effective management integrates addressing cardiovascular risk factors and appropriate antithrombotic strategies.

Impact:

  • This overview offers insights into the shifting paradigms in stable angina care.
  • Understanding current management is vital for clinicians to optimize patient outcomes.
  • The article serves as a reference for contemporary approaches to stable angina in 2015.

Keywords:
Angina pectorisKoronarangiografieLifestyle-Veränderungenanginaangorantianginal therapyantianginöse Therapiecoronarographiecoronary angiographylifestyle changesmedical therapymedikamentöse Therapiemodifications de l'hygiène de vietraitement antiangineuxtraitement médical

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.9K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

733

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
435
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
528
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
645
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
421
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
485
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
2.0K